Learn more

PREDDIE RICK E

Overview
  • Total Patents
    16
About

PREDDIE RICK E has a total of 16 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are CUROCELL INC, SHANGHAI CELL THERAPY RES INST and SHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD.

Patent filings in countries

World map showing PREDDIE RICK Es patent filings in countries
# Country Total Patents
#1 Canada 16

Patent filings per year

Chart showing PREDDIE RICK Es patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Preddie Rick E 16
#2 Bergmann Johanna E 14
#3 Pereddie Rick E 1
#4 Bergman Johanna 1
#5 Bergmann Johanna 1

Latest patents

Publication Filing date Title
CA2270360A1 A target for therapeutic reagents to stop the production of all forms of the abeta amyloid peptide (a.beta.) from the amyloid precursor protein (app) in humans
CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
CA2183900A1 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans
CA2153706A1 Agents for diagnosis, prevention and cure of myotonic dystrophy (md) in humans
CA2145214A1 Agents for pre-symptomatic diagnosis, prevention and cure huntington's disease (hd) in humans
CA2126787A1 Agents for the prevention and treatment of human alzheimer's disease
CA2104237A1 Agents for diagnosis, treatment and cure of amyotrophic lateral sclerosis in humans
CA2094169A1 Agents for the prevention and cure of huntington disease in humans: cdna, precursor polypeptide hormone and active hormone reconstructed from the antisense strand of the huntingtondisease gene, "huntingtin"
CA2090879A1 Targets for the prevention and cure of female breast cancer: bc534 and bc538, two reconstructed cdnas and encoded proteins antisense to the human tumour antigen p53 gene
CA2087737A1 Potential target for immunotherapy to prevent and cure rheumatoid arthritis and asthma in humans: cdna and protein structures for an intracellular activator of phospholipase a2 reconstructed from the antisense strand of human app gene
CA2087739A1 Putative target for an immunotherapeutic approach to prevent, and stop the neurological and other symptoms of lesch-nyhan syndrome in humans: reconstructed cdna and protein antisense to the human hprt gene
CA2087738A1 Potential target for an immunotherapeutic approach to stop huntington's chorea in humans: cdna and protein structures for an intracellular activator of the human glutamate receptor, brain lactate dehydrogenase and vacuolar atpase reconstructed from the antisense strand of baboon urate oxi dase gene
CA2086577A1 Potential target for immunotherapy to prevent replication of hiv (aids virus) in humans: cdna and protein for a putative regulator of hiv gag polyprotein expression reconstructed from the antisense strand of human p53 gene
CA2086576A1 Potential target for an immunotherapeutic approach to stop parkinson's disease in humans: cdna and protein structure for a putative activator of human dopamine receptor and human brain ca2+ channel protein reconstructed from the antisense strand of the human app gene
CA2085924A1 Putative therapeutic targets for the prevention and stoppage of human alzheimer's disease: cdna and amino acid sequence of a proteinase/esterase-like protein and a proteinase/protamine, truncated, modified form of the protein, anti ense to the alzheimer elated human app gene
CA2030967A1 Modular procedure used with a engineered dna implant for physical mapping/overlapping chromosomes with ready for gene isolation/ ready for sequencing contigs